NM_018116.4:c.104C>T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_018116.4(MSTO1):c.104C>T(p.Ala35Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018116.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000734 AC: 1AN: 136192Hom.: 0 Cov.: 20
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000559 AC: 4AN: 714974Hom.: 0 Cov.: 9 AF XY: 0.00000271 AC XY: 1AN XY: 368350
GnomAD4 genome AF: 0.00000734 AC: 1AN: 136192Hom.: 0 Cov.: 20 AF XY: 0.00 AC XY: 0AN XY: 65396
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.104C>T (p.A35V) alteration is located in exon 2 (coding exon 2) of the MSTO1 gene. This alteration results from a C to T substitution at nucleotide position 104, causing the alanine (A) at amino acid position 35 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at